Skip to main content
    M

    Medtronic PLC (MDT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $102.28
    -0.60 (-0.58%)

    Market Cap: $131.60B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Medtronic PLC (MDT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Medtronic (MDT) has a market cap of $131.60B and an enterprise value of $158.06B. Its trailing P/E is 17.9x.

    Total Valuation

    Enterprise value is 20.11% above the market cap, as debt exceeds cash.

    Market Cap$131.60B
    Enterprise Value$158.06B
    Latest price (Nov 17, 2026)$102.28

    Key Dates

    The next earnings report is set for Nov 24, 2026, before the open. The last ex-dividend date was Sep 25, 2026.

    Next Earnings DateNov 24, 2026, before the open
    Last Earnings DateSep 1, 2026
    Last Ex-Dividend DateSep 25, 2026
    Last Payment DateOct 16, 2026
    Fiscal Year EndApril

    Share Statistics

    The share count fell 0.64% in the quarter ended Jul 31, 2026 and shrank 0.52% a year over 2 years.

    Shares Outstanding1.28B
    Shares Change (YoY)-0.14%
    Shares Change (QoQ)-0.64%
    Share Count Growth (2Y CAGR)-0.52%

    Valuation Ratios

    Sales and book value multiples are 3.5x and 2.6x. Its year-end P/E ranged from 14.6x to 32.0x from 2016 to 2025.

    P/E Ratio17.9x
    Forward P/E16.9x
    P/S Ratio3.5x
    Forward P/S3.4x
    P/B Ratio2.6x
    P/FCF Ratio21.3x
    P/OCF Ratio16.4x
    PEG Ratio2.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 15.3x EBITDA and 25.7x free cash flow.

    EV / Earnings30.0x
    EV / Sales4.2x
    EV / EBITDA15.3x
    EV / EBIT21.6x
    EV / FCF25.7x

    Price Statistics

    The stock is up 8.35% over 52 weeks and trades 8.90% above its 50-day average.

    Beta (1Y)0.16
    52-Week Change+8.35%
    1-Month Change+10.25%
    3-Month Change+9.54%
    6-Month Change+32.38%
    5-Year Change-19.46%
    10-Year Change+17.70%
    Total Return (1Y)+11.38%
    Total Return (3Y CAGR)+13.46%
    Total Return (5Y CAGR)-0.26%
    Return vs SPY (1Y)-8.51%
    Max Drawdown (1Y)-30.10%
    Max Drawdown (3Y)-30.10%
    Sharpe Ratio (1Y)0.12
    Correlation with SPY (1Y)0.09
    50-Day Average$93.92
    200-Day Average$87.41
    52-Week Range$72.06 to $106.20
    RSI (14 Days)61.7
    Average Volume (20 Days)7.64M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.07x current liabilities, and total debt is 0.56x shareholder equity.

    Current Ratio2.07x
    Quick Ratio1.54x
    Debt / Equity0.56x
    Debt / EBITDA2.74x
    Debt / FCF4.59x
    Interest Coverage10.11x

    Returns and Efficiency

    Return on invested capital is 7.46% over the last 12 months, against a 5-year average of 6.48%.

    Return on Equity (ROE)10.49%
    Return on Assets (ROA)5.65%
    Return on Invested Capital (ROIC)7.46%
    Return on Capital Employed (ROCE)8.99%
    ROE (5Y Average)8.78%
    ROA (5Y Average)4.83%
    ROIC (5Y Average)6.48%
    Asset Turnover0.41x
    Inventory Turnover2.16x
    Receivables Turnover5.78x
    Cash Conversion Cycle158 days

    Taxes

    Income tax took 20.19% of pretax income over the last 12 months.

    Income Tax (TTM)$1.33B
    Effective Tax Rate20.19%

    Scores

    MDT has an Altman Z-Score of 3.17, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score3.17
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $37.54B over the last 12 months is up 9.77% from the 12 months before.

    Revenue$37.54B
    Revenue Growth (YoY)+9.77%
    Gross Profit$24.41B
    Operating Income$6.79B
    Pretax Income$6.60B
    Net Income$5.27B
    EBITDA$10.27B
    EBIT$7.33B
    Reported EPS (TTM)$5.72

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 53.83% of the $93.31B in total assets.

    Cash and Equivalents$1.69B
    Total Debt$28.15B
    Net Debt$26.46B
    Net Debt Per Share$20.68
    Working Capital$12.59B
    Shareholder Equity$50.23B
    Book Value Per Share$39.25
    Tangible Book Value-$3.19B
    Total Assets$93.31B
    Total Liabilities$42.46B

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    After $1.90B of capital spending, operating cash flow left $6.13B of free cash flow.

    Operating Cash Flow$8.04B
    Capital Expenditures$1.90B
    Free Cash Flow$6.13B
    FCF Per Share$4.79
    Depreciation and Amortization$2.94B
    Dividends Paid$3.65B
    Share Repurchases$1.18B

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is 18.08%, against a 5-year average of 17.43%.

    Gross Margin65.01%
    Operating Margin18.08%
    Pretax Margin17.59%
    Net Margin14.03%
    EBITDA Margin27.35%
    EBIT Margin19.52%
    FCF Margin16.33%
    Gross Margin (5Y Average)65.87%
    Operating Margin (5Y Average)17.43%
    Net Margin (5Y Average)13.37%

    Growth

    Revenue grew 5.21% a year over 3 years, and EPS 1.43% a year.

    Revenue Growth (3Y CAGR)+5.21%
    Revenue Growth (5Y CAGR)+3.84%
    EPS Growth (3Y CAGR)+1.43%
    EPS Growth (5Y CAGR)+4.54%
    FCF Growth (3Y CAGR)+5.81%
    FCF Growth (5Y CAGR)+2.12%
    Operating Income Growth (3Y CAGR)+5.64%
    Book Value Per Share Growth (2Y CAGR)+0.68%

    Revenue and profit by year

    Dividends and Yields

    MDT pays out 45.55% of earnings as dividends.

    Dividend Per Share (Annual)$2.88
    Dividend Yield2.82%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+1.96%
    Dividend Growth (5Y CAGR)+4.42%
    Payout Ratio45.55%
    FCF Payout Ratio59.52%
    Earnings Yield5.59%
    FCF Yield4.68%
    Buyback Yield0.15%
    Shareholder Yield2.94%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Sep 27, 1999.

    Last Split DateSep 27, 1999
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 11 similar companies, MDT has the 8th highest P/E.

    P/E Ratio17.9x vs 22.2x median
    P/S Ratio3.5x vs 3.6x median
    ROIC7.46% vs 8.43% median
    Revenue Growth (Trailing 4 Quarters, YoY)+9.77% vs +8.50% median
    Dividend Yield2.82% vs 0.10% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.41% and EPS growth at 7.63% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.41%
    EPS Growth Forecast (2Y CAGR)+7.63%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MDT

    What is MDT's market cap?

    Medtronic has a market cap of $131.60B. Its enterprise value, which adds debt and subtracts cash, is $158.06B.

    What is MDT's P/E ratio?

    Medtronic has a trailing P/E ratio of 17.9x and a forward P/E of 16.9x.

    How many shares of MDT are outstanding?

    Medtronic has 1.28B shares outstanding. The count is down 0.14% from a year earlier.

    Does MDT pay a dividend?

    Yes. Medtronic pays $2.88 a share a year, a dividend yield of 2.82%.

    How much debt does MDT have?

    Medtronic has $28.15B of total debt and $1.69B of cash and equivalents, a net debt position of $26.46B.